Waldir Ventura Filho
IEEE Number: 92757194
President of IEEE CS UFABC Student Chapter
Santo André – São Paulo – Brazil
NEGLECTED TROPICAL DISEASES
•
Group of parasitic and bacterial diseases
•
Affect more than 1.5 billion people worldwide
•
Related to poverty and lack of access to minimum health and sanitation
•
Affect physical and cognitive development
•
Examples: barber bug fever, ascariasis, elephantiasis, leishmaniasis
DRUGS OVERVIEW
•
Drugs for NDT did not evolved as the same of heart diseases, which affects rich
countries as well
•
The risk of investment would be high because of poor countries
•
Rigorous market analysis for new drugs because is related to the welfare of
human beings
•
Accuracy needs to be high since it deals with lives
•
By the year 2010 more than half drugs introduced to the market was only na
incremental innovation
DRUGS RESEARCH
•
R&D for drugs consists of a long chain from basic research, pass through clinical
analysis before the manufactuiring and launch
•
According to FDA, development of a new drug takes 10 to 15 years
•
Scientific community takes effort in researches
•
Limitation in the public’s purchasing power limitates the production
THE SOLUTION
•
Create a new business model
•
Integrate drug innovation research with producers
•
Contemplate the whole process
• Development
• Clinical Analysis
• Production
• Launch
•
Contemplate demand of NTD
HOW MAKE IT HAPPEN
•
Analysis of IEEE CS 2022 report
•
Understand the 23 technologies in 2022
•
Evaluation of technologies
Use The Open Intellectual Property Movement
THE PROJECT
•
Colaborative platform
•
Join forces of each part of the process
•
Four stages of the production
•
Four playerrs on the platform
Player
1
Player
4
Player
2
Player
3
PLAYERS
•
Player 1: Research institutions
• Responsible for creating a new molecule
• Scientists, Universities Professors
• Relationship with existing researches
• Co-creating ideas
•
Player 2: Institutes of Clinical Analysis
• Responsible for clinical analysis
• Whole process of clinical analysis
• Companies with know-how in the area
PLAYERS
•
Player 3: Pharmaceutical Companies
• Responsible for the production
• Produce and launch the drug to the market
• Companies able to produce on a large scale
• Accredited Company
•
Player 4: Manager (may be the World Health Organization)
• Manage the entire system
• Integrate all the players
• Follow and moderate the steps of the work
PLATFORM ADVANTAGES
•
Managed by WHO
•
Selection of best players
•
Reduce time of production
•
Exclude the lack between the players
•
Integrated idea
•
Ease of communication
•
Co-creation
IMAGE REFERENCES
http://3.bp.blogspot.com/anoJqdIDJIE/Tocsna77ldI/AAAAAAAAALY/gZob2qvfRfM/s1600/Picture2.png